Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoglobulin-producing tumors.

R E Matus, C E Leifer

    The Veterinary Clinics of North America. Small Animal Practice
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Canine multiple myeloma and macroglobulinemia are common. Alkylating agents and prednisone can extend survival, with supportive care crucial for optimal outcomes in dogs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Doxorubicin-induced cardiotoxicosis. Clinical features in 32 dogs.

    Journal of veterinary internal medicine·1992
    Same author

    Prognostic factors in dogs with lymphoma and associated hypercalcemia.

    Journal of veterinary internal medicine·1991
    Same author

    Canine ehrlichiosis in six dogs with persistently increased antibody titers.

    Journal of veterinary internal medicine·1991
    Same author

    Etoposide (VP-16). Retrospective analysis of treatment in 13 dogs with lymphoma.

    Journal of veterinary internal medicine·1990
    Same author

    Lymphomas in dogs. A morphologic, immunologic, and clinical study.

    Cancer·1990
    Same author

    Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981).

    Journal of the American Veterinary Medical Association·1989

    Area of Science:

    • Veterinary Oncology
    • Canine Hematology

    Background:

    • Multiple myeloma and macroglobulinemia are the most frequent immunoglobulin-producing neoplasms in dogs.
    • These conditions significantly impact canine health and require specialized treatment approaches.

    Purpose of the Study:

    • To review the current understanding and management of multiple myeloma and macroglobulinemia in dogs.
    • To emphasize the importance of treatment and supportive care for improving prognosis.

    Main Methods:

    • Review of existing literature on canine multiple myeloma and macroglobulinemia.
    • Discussion of treatment protocols, including alkylating agents and prednisone.
    • Emphasis on clinical staging and response to therapy for prognosis.

    Main Results:

    Related Experiment Videos

    • Treatment with alkylating agents and prednisone can significantly prolong survival in affected dogs.
    • Supportive management of complications is essential for optimal patient care.
    • Clinical staging aids prognosis, but response to therapy is highly significant, especially in advanced cases.

    Conclusions:

    • While a cure is unlikely, effective treatments can lead to extended, good-quality life for dogs with these neoplasms.
    • Veterinarians should encourage evaluation for treatment, offering hope for a normal, healthy life for over a year in most cases.
    • Investigational combination drug protocols at referral centers should be considered for high-risk patients.